CAS 835598-94-2
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
GLX351322
CAS :GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.Formule :C21H25N3O5SDegré de pureté :99.93%Couleur et forme :SolidMasse moléculaire :431.51GLX351322
CAS :<p>GLX351322 is a small molecule drug that blocks the activity of TNF-α, which is a proinflammatory cytokine. The drug has been shown to reduce insulin resistance and improve insulin sensitivity in diabetic patients. GLX351322 also has an anti-inflammatory effect by reducing chronic cough and suppressing cholesterol synthesis in rats. It is a synthetic compound that binds to the response element-binding protein (RBP) and prevents the binding of transcription factors to DNA. This prevents the production of inflammatory cytokines and reactive oxygen species (ROS) by immune cells, which are responsible for synaptic dysfunction and neuronal cell death in Alzheimer's disease patients. GLX351322 has been found to have no adverse effects on healthy subjects after short-term exposure.END>></p>Formule :C21H25N3O5SDegré de pureté :Min. 95%Masse moléculaire :431.51 g/mol
